Back
Kalaris Therapeutics Inc KLRS · Insights
Kalaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development a... Price2.3
Market Cap54.75 M
Float8.24 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro